Compounds > neurotensin (8-13)
Page last updated: 2024-09-03

neurotensin (8-13) and raclopride

neurotensin (8-13) has been researched along with raclopride in 1 studies

Compound Research Comparison

Studies
(neurotensin (8-13))		Trials
(neurotensin (8-13))		Recent Studies (post-2010)
(neurotensin (8-13))		Studies
(raclopride)		Trials
(raclopride)		Recent Studies (post-2010) (raclopride)
660101,802132419

Protein Interaction Comparison

ProteinTaxonomyneurotensin (8-13) (IC50)raclopride (IC50)
D(2) dopamine receptorHomo sapiens (human)0.052
D(2) dopamine receptorMus musculus (house mouse)0.032
D(2) dopamine receptorRattus norvegicus (Norway rat)0.0279

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Finnman, UB; Fuxe, K; Hedlund, PB; Li, XM; Von Euler, G1

Other Studies

1 other study(ies) available for neurotensin (8-13) and raclopride

ArticleYear
The C-terminal neurotensin-(8-13) fragment potently modulates rat neostriatal dopamine D2 receptors.
    European journal of pharmacology, 1993, Mar-30, Volume: 234, Issue:1

    Topics: Animals; Binding, Competitive; In Vitro Techniques; Male; Neostriatum; Neurotensin; Peptide Fragments; Raclopride; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides

1993